|
US20050272101A1
(en)
|
2004-06-07 |
2005-12-08 |
Prasad Devarajan |
Method for the early detection of renal injury
|
|
PL1799269T3
(pl)
*
|
2004-09-28 |
2017-01-31 |
Quark Pharmaceuticals, Inc. |
Oligorybonukleotydy i sposoby ich zastosowania do leczenia łysienia, ostrej niewydolności nerek i innych chorób
|
|
US20090170143A1
(en)
*
|
2004-12-20 |
2009-07-02 |
Lars Otto Uttenthal |
Determination of Neutrophil Gelatinase-Associated Lipocalin (NGAL) as a Diagnostic Marker for Renal Disorders
|
|
WO2006078717A2
(en)
*
|
2005-01-19 |
2006-07-27 |
Beth Israel Deaconess Medical Center |
Lipocalin 2 for the treatment, prevention, and management of cancer metastasis, angiogenesis, and fibrosis
|
|
US20070037232A1
(en)
*
|
2005-03-31 |
2007-02-15 |
Barasch Jonathan M |
Detection of NGAL in chronic renal disease
|
|
US20080090304A1
(en)
*
|
2006-10-13 |
2008-04-17 |
Barasch Jonathan Matthew |
Diagnosis and monitoring of chronic renal disease using ngal
|
|
US7825099B2
(en)
*
|
2006-01-20 |
2010-11-02 |
Quark Pharmaceuticals, Inc. |
Treatment or prevention of oto-pathologies by inhibition of pro-apoptotic genes
|
|
JP4865377B2
(ja)
|
2006-03-28 |
2012-02-01 |
国立大学法人 新潟大学 |
ヒトメガリンの測定方法
|
|
US7662578B2
(en)
|
2006-04-21 |
2010-02-16 |
Children's Hospital Medical Center |
Method and kit for the early detection of impaired renal status
|
|
US20080090765A1
(en)
*
|
2006-05-25 |
2008-04-17 |
The Trustees Of Columbia University In The City Of New York |
Compositions for modulating growth of embryonic and adult kidney tissue and uses for treating kidney damage
|
|
ATE539351T1
(de)
|
2006-05-30 |
2012-01-15 |
Antibodyshop As |
Verfahren zur schnellen beurteilung der schwere eines traumas
|
|
EP2602624A1
(en)
*
|
2006-08-07 |
2013-06-12 |
Antibodyshop A/S |
Diagnostic test to exclude significant renal injury
|
|
US8524462B2
(en)
*
|
2006-11-14 |
2013-09-03 |
Alere San Diego, Inc. |
Methods and compositions for diagnosis and prognosis of renal artery stenosis
|
|
EP2095107B1
(en)
*
|
2006-11-14 |
2014-07-02 |
Alere San Diego, Inc. |
Methods for risk assignment
|
|
JP5128828B2
(ja)
*
|
2007-02-16 |
2013-01-23 |
月桂冠株式会社 |
抗炎症剤及び抗酸化剤
|
|
WO2008113363A1
(en)
*
|
2007-03-21 |
2008-09-25 |
Bioporto Diagnostics A/S |
Diagnostic test for renal injury
|
|
SI2170403T1
(sl)
*
|
2007-06-27 |
2014-07-31 |
Quark Pharmaceuticals, Inc. |
Sestavki in postopki za inhibicijo ekspresije pro-apoptotskih genov
|
|
US8846036B2
(en)
|
2007-10-19 |
2014-09-30 |
Abbott Laboratories |
Antibodies that bind to mammalian NGAL and uses thereof
|
|
US8592170B2
(en)
|
2008-03-12 |
2013-11-26 |
The Trustees Of Columbia University In The City Of New York |
High molecular weight Ngal as a biomarker for chronic kidney disease
|
|
US8030097B2
(en)
*
|
2008-04-30 |
2011-10-04 |
Versitech Limited and R & C Biogenius Limited |
Lipocalin-2 as a prognostic and diagnostic marker for heart and stroke risks
|
|
BRPI0912683A2
(pt)
|
2008-05-15 |
2016-01-26 |
Transmolecular Inc |
tratamento de tumores metastáticos
|
|
US20100122355A1
(en)
*
|
2008-07-16 |
2010-05-13 |
Neal Paragas |
Transgenic Reporter Mouse and Method for Use
|
|
US20110268818A1
(en)
*
|
2008-09-18 |
2011-11-03 |
Jonathan Barasch |
Ngal-binding siderophores and use thereof to treat iron deficiency and iron overload
|
|
CA2741566A1
(en)
*
|
2008-11-03 |
2010-06-03 |
Schering Corporation |
Inflammatory bowel disease biomarkers and related methods of treatment
|
|
ES2718731T3
(es)
*
|
2008-11-21 |
2019-07-04 |
Future Medical Diagnostics Co Ltd |
Métodos, dispositivos y kits para detectar o monitorizar la lesión renal aguda
|
|
US20100233740A1
(en)
*
|
2009-02-12 |
2010-09-16 |
Jonathan Barasch |
Use of urinary ngal to distinguish kidney disease and predict mortality in subjects with cirrhosis
|
|
US20100233739A1
(en)
*
|
2009-02-12 |
2010-09-16 |
Jonathan Barasch |
Use of urinary ngal to diagnose unilateral and bilateral urinary obstruction
|
|
US8628930B2
(en)
|
2009-04-27 |
2014-01-14 |
Niigata University |
Use of megalin in urine as marker for detecting renal disorder
|
|
JP5424702B2
(ja)
|
2009-04-27 |
2014-02-26 |
国立大学法人 新潟大学 |
尿中ヒトメガリンを測定することを含む腎疾患検出方法
|
|
EP2292284B1
(en)
*
|
2009-09-04 |
2014-02-26 |
B. Braun Avitum AG |
Kidney substitution treatment machine
|
|
HRP20171291T1
(hr)
|
2010-02-04 |
2017-10-20 |
Morphotek, Inc. |
Polipeptidi i konjugati klorotoksina i njihove uporabe
|
|
WO2011140554A1
(en)
*
|
2010-05-07 |
2011-11-10 |
The Trustees Of Columbia University In The City Of New York |
Ngal and urinary tract infection
|
|
EP3165533B1
(en)
|
2010-05-11 |
2020-04-08 |
Fred Hutchinson Cancer Research Center |
Chlorotoxin variants, conjugates and methods for their use
|
|
JP2013529907A
(ja)
|
2010-05-24 |
2013-07-25 |
ザ トラスティーズ オブ コロンビア ユニヴァーシティ イン ザ シティ オブ ニューヨーク |
Ｎｇａｌタンパク質変異体及びその使用
|
|
EP2622095B1
(en)
|
2010-10-01 |
2016-09-14 |
INSERM (Institut National de la Santé et de la Recherche Médicale) |
Methods for predicting the progression and treating a chronic kidney disease in a patient
|
|
US20140057838A1
(en)
*
|
2011-04-11 |
2014-02-27 |
The Trustees Of Columbia University In The City Of New York |
Osteoblast-expressed lipocalin 2 regulates glucose metabolism
|
|
WO2012167092A2
(en)
*
|
2011-06-03 |
2012-12-06 |
The Regents Of The University Of Colorado, A Body Corporate |
Uses of and methods of treatment with cystathionine
|
|
EP2925337B1
(en)
|
2012-11-21 |
2019-07-03 |
The Trustees of Columbia University in the City of New York |
Mutant ngal proteins and uses thereof
|
|
CA2913029A1
(en)
|
2012-12-10 |
2014-06-19 |
Fred Hutchinson Cancer Research Center |
Lipocalin fusion partners
|
|
US11559580B1
(en)
|
2013-09-17 |
2023-01-24 |
Blaze Bioscience, Inc. |
Tissue-homing peptide conjugates and methods of use thereof
|
|
CA3220985A1
(en)
|
2014-09-29 |
2016-04-07 |
Seattle Cancer Care Alliance |
Compositions, kits, and methods to induce acquired cytoresistance using stress protein inducers
|
|
JP5866053B1
(ja)
*
|
2014-12-15 |
2016-02-17 |
株式会社ファンケル |
皮膚粘弾性のマーカー及びその利用
|
|
WO2017027858A1
(en)
|
2015-08-12 |
2017-02-16 |
The Trustees Of Columbia University In The City Of New York |
Methods of treating volume depletion and kidney injury
|
|
JP6909208B2
(ja)
|
2015-09-17 |
2021-07-28 |
アムジェン インコーポレイテッド |
Ｉｌ２３経路バイオマーカーを使用するｉｌ２３アンタゴニストに対する臨床応答の予測
|
|
US10905682B2
(en)
|
2015-12-01 |
2021-02-02 |
Cornell University |
Use of mitochondrial iron chelators for treatment of chronic obstructive pulmonary disease
|
|
AU2016379157A1
(en)
|
2015-12-22 |
2018-06-21 |
Amgen Inc. |
CCL20 as a predictor of clinical response to IL23-antagonists
|
|
EP3184116B1
(en)
*
|
2015-12-23 |
2020-09-16 |
National Taiwan Normal University |
Neutrophil gelatinase-associated lipocalin for use in prevention or treatment of polycystic kidney disease
|
|
TWI581802B
(zh)
*
|
2015-12-23 |
2017-05-11 |
國立臺灣師範大學 |
嗜中性白血球膠原蛋白質酶相關疏水性蛋白質之製藥用途
|
|
AU2017250359B2
(en)
|
2016-04-15 |
2022-06-16 |
Blaze Bioscience, Inc. |
Methods of treating breast cancer
|
|
CN110996985A
(zh)
*
|
2017-06-23 |
2020-04-10 |
Aki医疗有限公司 |
用于预防和治疗急性肾损伤的组合物
|
|
US11298564B2
(en)
|
2020-03-10 |
2022-04-12 |
Dennis M. Anderson |
Medical, surgical and patient lighting apparatus, system, method and controls with pathogen killing electromagnetic radiation
|
|
CN113075371B
(zh)
*
|
2021-03-22 |
2022-11-18 |
重庆医药高等专科学校 |
一种药物崩解仪
|